Pyrazinamide-induced sideroblastic anemia

MeSH terms

• 5-Aminolevulinate Synthetase / antagonists & inhibitors
• Anemia, Sideroblastic / blood
• Anemia, Sideroblastic / chemically induced*
• Anemia, Sideroblastic / drug therapy
• Antitubercular Agents / administration & dosage
• Antitubercular Agents / adverse effects*
• Antitubercular Agents / therapeutic use
• Aza Compounds / administration & dosage
• Aza Compounds / therapeutic use
• Bone Marrow / pathology*
• Chemical and Drug Induced Liver Injury / etiology
• Drug Therapy, Combination
• Ethambutol / administration & dosage
• Ethambutol / therapeutic use
• Female
• Fluoroquinolones
• Hemolysis / drug effects
• Humans
• Isoniazid / administration & dosage
• Isoniazid / adverse effects
• Isoniazid / therapeutic use
• Middle Aged
• Moxifloxacin
• Peritonitis, Tuberculous / complications
• Peritonitis, Tuberculous / drug therapy*
• Pyrazinamide / administration & dosage
• Pyrazinamide / adverse effects*
• Pyrazinamide / therapeutic use
• Pyridoxine / therapeutic use
• Quinolines / administration & dosage
• Quinolines / therapeutic use
• Rifampin / administration & dosage
• Rifampin / therapeutic use
• alpha-Thalassemia / complications